To be eligible, the project must aim at improving the quality of care for people living with HIV, viral hepatitis or tuberculosis, focusing on at least two of the following aspects:
- Reduction of barriers to testing, prevention and treatment for HIV, viral hepatitis and TB, including stigmatization and focusing on key population groups
- Improved quality of care and monitoring of care instruments (including eHealth solutions)
- Building partnership with other health institutions at national and/or international level
- Capacity building at national level, including training activities
Deadline for submission of stage 1 proposals is 1 March 2020. The duration of a stage 1 project should not exceed 12 months.
The following countries are eligible for the first wave: Ukraine, Georgia, Romania, Moldova, Estonia, Latvia and Lithuania.
Eligible Institutions and Individuals
Public health care institutions, universities, university-associated institutes, private and public hospitals, and non-governmental not for profit organizations.
Applicants must be health care providers or researchers with a permanent employment at an eligible institution. Applications must be endorsed by the governing body of the institution. In case the individual(s) who applied for the grant leaves the institution, the grant as well as the responsibility for completing the project remains with the governing body of the institution.
Stage 2 applications
Institutions/organizations that successfully carried out a stage 1 project are eligible to apply for a stage 2 grant. The stage 2 projects should build on outcomes, insights and lessons learnt from the stage 1 pilot. Stage 2 projects will have a running time of up to three years.
Deadline for submission of a stage 2 proposal: 31 January 2022. Additional information and requirements have been communicated to the eligible groups.